Ginkgo Bioworks Holdings
Earnings Surprise
Analysts estimated DNA earnings of $-1.25 per share this quarter (Q3). DNA's actual earnings were $-1.45 per share.
DNA EPS surprise of -15.78%Analysts estimated DNA earnings of $-1.58 per share this quarter (Q2). DNA's actual earnings were $-1.10 per share.
DNA EPS surprise of 30.48%Analysts estimated DNA earnings of $-1.79 per share this quarter (Q1). DNA's actual earnings were $-1.68 per share.
DNA EPS surprise of 6.02%Analysts estimated DNA earnings of $-1.79 per share this quarter (Q4). DNA's actual earnings were $-2.00 per share.
DNA EPS surprise of -11.88%Analysts estimated DNA earnings of $-2.75 per share this quarter (Q3). DNA's actual earnings were $-0.94 per share.
DNA EPS surprise of 65.88%Analysts estimated DNA earnings of $-3.15 per share this quarter (Q2). DNA's actual earnings were $-2.80 per share.
DNA EPS surprise of 11.14%Analysts estimated DNA earnings of $-0.08 per share this quarter (Q1). DNA's actual earnings were $-0.08 per share.
DNA EPS surprise of 5.25%Analysts estimated DNA earnings of $-0.10 per share this quarter (Q4). DNA's actual earnings were $-0.09 per share.
DNA EPS surprise of -7.79%